POLYTECH Health & Aesthetics gets approval for breast Implants

POLYTECH sold the three millionth implant since its establishment in 1986. The company is the only German manufacturer a...

December 21, 2018 | Friday | News
Merck gives CAR-T rights to Intrexon

Merck, a leading science and technology company, has evolved its agreement with Intrexon Corporation for the development...

December 21, 2018 | Friday | News
New stem cell research has identified novel therapeutic targets for MS treatment

The preclinical findings published in Cell Reports reveal that activation of a specific transcription factor induces a p...

December 20, 2018 | Thursday | News
Gilead Sciences and Scholar Rock announce strategic collaboration

Gilead Sciences and Scholar Rock Holding Corporation have announced that the companies have entered into a strategi...

December 20, 2018 | Thursday | News
Bayer gets EU nod for Jivi, but to compete ahead: GlobalData

Pharma major, Bayer has recently received the European Commission approval for its hemophilia A long-acting injectable m...

December 20, 2018 | Thursday | News
Gritstone Oncology announces publication of Neoantigen Identification Capabilities of its AI Platform, EDGE

Gritstone Oncology, Inc., a clinical-stage biotechnology company developing the next generation of cancer immunotherapie...

December 20, 2018 | Thursday | News
Smith to acquire Ceterix for up to $105M

Singapore - Smith & Nephew  announces that it has agreed to acquire Ceterix Orthopaedics and its Novo...

December 19, 2018 | Wednesday | News
Amgen, Molecular Partners team up for Immuno-Oncology

Amgen and Molecular Partners, a clinical-stage biotech company pioneering the use of DARPin® therapeutics, have...

December 19, 2018 | Wednesday | News
Erasca completes $42M series A financing round

Erasca, a company dedicated to advancing exceptional scientific approaches to erase cancer, has completed a $42 million ...

December 19, 2018 | Wednesday | News
Lexicon Pharma announces positive topline clinical data for LX9211

Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...

December 19, 2018 | Wednesday | News
DelSiTech, Innovare sign licensing agrrement for the development of a long acting HIV Therapy

DelSiTech Ltd, a Finnish drug delivery technology and drug development company and InnovareR&D, a leading Mexican ph...

December 19, 2018 | Wednesday | News
IFM Therapeutics announces discovery of new immune system triggers

IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel t...

December 19, 2018 | Wednesday | News
Staten Biotechnology, Novo Nordisk enter into a deal worth $430M

Staten Biotechnology has signed a dyslipidaemia licence option deal worth US$430 million with Novo Nordisk. Unde...

December 18, 2018 | Tuesday | News
Global Cannabis Partnership expands to 31 members

The Global Cannabis Partnership (GCP) is pleased to announce the addition of seven new Members as it continues to grow i...

December 18, 2018 | Tuesday | News
Orchard Therapeutics, SIRION Biotech partners for gene therapy

Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patien...

December 18, 2018 | Tuesday | News
Bristol-Myers Squibb receives positive CHMP Opinion recommending Sprycel for Pediatric Patients

Bristol-Myers Squibb Company has announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...

December 18, 2018 | Tuesday | News
Bristol-Myers Squibb, Boston Medical Centre announce collaboration

Bristol-Myers Squibb Company and Boston Medical centre, a private, not-for-profit, academic medical centre has announced...

December 18, 2018 | Tuesday | News
Merck launches new Steritest NEO Device

Merck has launched the latest evolution in sterility testing devices, the Steritest™ NEO device, which provides sa...

December 18, 2018 | Tuesday | News